Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.2258 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(C)C(=O)C1=CC=C2OCOC2=C1
InChI
InChIKey=VKEQBMCRQDSRET-UHFFFAOYSA-N
InChI=1S/C11H13NO3/c1-7(12-2)11(13)8-3-4-9-10(5-8)15-6-14-9/h3-5,7,12H,6H2,1-2H3
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.2258 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Methylone (3, 4-Methylenedioxy-N-methylcathinone), a β-keto analog of 3,4-methylenedioxy-N-methylamphetamine (MDMA) is a stimulant and psychoactive drug. Methylone is a popular drug of abuse that strongly increases the release of the three monoamines: dopamine, serotonin (5-HT) and norepinephrine. In addition, methylone inhibits plasma membrane catecholamine transporters but only weakly inhibit the vesicle transporter. In April 2013, methylone was listed in the Schedule 1 substance under the Controlled Substances Act.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone. | 2007 Aug 15 |
|
[Analysis of designer drugs detected in the products purchased in fiscal year 2006]. | 2008 Oct |
|
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. | 2010 Jun |
|
Metabolism of designer drugs of abuse: an updated review. | 2010 Jun 1 |
|
Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. | 2010 May |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:25:43 GMT 2023
by
admin
on
Sat Dec 16 00:25:43 GMT 2023
|
Record UNII |
L4I4B1R01F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7540
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Methylone
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
186028-79-5
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
SUB90507
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
45789647
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
METHYLONE
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
100000140993
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
C400939
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
DTXSID80870167
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
7997
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY | |||
|
L4I4B1R01F
Created by
admin on Sat Dec 16 00:25:43 GMT 2023 , Edited by admin on Sat Dec 16 00:25:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
No free form was detected. After hydrolysis, 74 ng/mL of 3-HMMC was observed in a methylone abuser's urine specimen.
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VITRO
Scientific Literature
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN VITRO
MAJOR
|
||
|
METABOLITE -> PARENT |
No free form was detected. After hydrolysis, 170 ng/mL of $-HMMC was observed in a methylone abuser's urine specimen.
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|